Vertex Pharmaceuticals (VRTX) Operating Income (2009 - 2026)
Vertex Pharmaceuticals' Operating Income was $1.25 billion in Q2 2026, up 8.3% from $1.15 billion a year earlier and up 9.6% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Operating Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vertex Pharmaceuticals' Operating Income was $4.78 billion through Jun 30, 2026, up 21.8% year-over-year; for FY2025, it came in at $4.17 billion.
- Operating Income shows a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- In earlier years, Operating Income was -$232.9 million in FY2024, $3.83 billion in FY2023 (-11.0%), $4.31 billion in FY2022 (+54.8%) and $2.78 billion in FY2021 (-2.6%).
- The Q2 2026 figure marks the highest quarterly Operating Income in data going back to Q1 2009.
- Compared with a year earlier, Operating Income has increased for four straight quarters, with growth averaging 11.3% over the last seven quarters.
- The best year-over-year quarter for Operating Income over five years was Q1 2026 (growth of 80.6%); the worst was Q1 2025 (a decline of 44.7%).
- Per Business Quant data, VRTX's Operating Income in the three quarters before Q2 2026 was $1.14 billion (Q1 2026), $1.21 billion (Q4 2025) and $1.19 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Bn |
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.15 Bn |
| Mar 31, 2025 | 630.10 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | -3.51 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 988.50 Mn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 779.00 Mn |
| Dec 31, 2022 | 1.03 Bn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.04 Bn |
| Dec 31, 2021 | 877.70 Mn |
| Sep 30, 2021 | 1.05 Bn |
API Access
Vertex Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();